|
[1]Metcalf JV, Bhopal RS, Gray J, et al.Incidence and preva-lence of primary biliary cirrhosis in the city of Newcastle up-on Tyne, England[J].Int J Epidemiol, 1997, 26 (4) :830-836.
|
|
[2]Kim WR, Lindor KD, Locke GR III, et al.Epidemiology andnatural history of primary biliary cirrhosis in a US[J].Gastro-enterology, 2000, 119 (6) :1631-1636.
|
|
[3]Gershwin ME, Selmi C, Worman HJ, et al.Risk factors andcomorbidities in primary biliary cirrhosis:a controlled inter-view-based study of 1032 patients[J].Hepatology, 2005, 42 (5) :1194-12.
|
|
[4]Ala A, Stanca CM, Bu-Ghanim M, et al.Increased preva-lence of primary biliary cirrhosis near super fund toxic wastesites[J].Hepatology, 2006, 43 (3) :525-531.
|
|
[5]Zein CO, Beatty K, Post AB, et al.Smoking and increased se-verity of hepatic fibrosis in primary biliary cirrhosis:A cross vali-dated retrospective assessment[J].Hepatology, 2006, 44 (6) :1564-1571.
|
|
[6]Leung PS, Park O, Tsuneyama K, et al.Induction of primarybiliary cirrhosis inguinea pigs following chemical xenobioticimmunization[J].J Immunol, 2007, 179 (4) :2651-2657.
|
|
[7]Hirschfield GM, Liu X, Xu C, et al.Primary biliary cirrhosisassociated with HLA, IL12A, and IL12RB2 variants[J].NEngl J Med, 2009, 360 (24) :2544-2555.
|
|
[8]Nakamura M, Yasunami M, Kondo H, et al.Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary bili-ary cirrhosis (PBC) :he HLA-DRB1 polymorphism deter-mines the relative risk of antinuclear antibodies for diseaseprogression in PBC[J].Hepatol Res, 2010, 40 (5) :494-504.
|
|
[9]陈燕, 周晔, 邓安梅, 等.中国东部汉族人群原发性胆汁性肝硬化与HLA2DRB1相关性分析[J].中国免疫学杂志, 2006, (22) 12:1143-1145.
|
|
[10]Muratori L, Granito A, Muratori P, et al.Antimitochondrialantibodies and other antibodies in primary biliary cirrhosis:di-agnostic and prognosticvalue[J].Clin Liver Dis, 2008, 12 (2) :261-276.
|
|
[11]Cavazzana I, Angela C, Paolo A, et al.Anti-RNA polymera-seIII antibodies:a marker of systemic sclerosis with rapid on-set and skin thickening progression[J].Autoimmun Rev, 2009, 8 (7) :580-584.
|
|
[12]Itoh S, Ichida T, Yoshida T, et al.Autoantibodies against a210kD aglycoprotein of the nuclearpore complex as a prog-nostic marker in patients with primary biliary cirrhosis[J].JGastroenterol Hepatol, 1998, 13 (3) :257-265.
|
|
[13]Muratori P, Muratori L, Ferrari R, et al.Characterization andclinical impact of antinuclear antibodies in primary biliary cir-rhosis[J].Am J Gastroenterol, 2003, 9 (2) 8:431-437.
|
|
[14]Miyachi K, Hankins RW, Matsushima H, et al.Profile andclinical significance of anti-nuclear envelope antibodiesfound in patients with primary biliary cirrhosis:a multicenterstudy[J].J Autoimmun, 2003, 20 (3) :247-254.
|
|
[15]VandeWater J, Turchany J, Leung PS, et al.Molecular mimicryin primary biliary cirrhosis.Evidence for biliary epithelial expres-sion of a moleculecross-reactive with pyruvate dehydrogenasecomplex-E2[J].J Clin Invest, 1993, 91 (6) :2653-2664.
|
|
[16]Guldner HH, Szostecki C, Gr tzinger T, et al.IFN enhanceexpression of Sp100, an autoantigen in primary biliary cirrho-sis[J].J Immunol, 1992, 149 (12) :4067-4073.
|
|
[17]Czaja AJ.Autoantibodies as prognostic markers in autoimmuneliver disease[J].Dig Dis Sci, 2010, 55 (8) :2144-2161.
|
|
[18]Nakamura M, Kondo H, Mori T, et al.Anti-gp210and anti-centromere antibodies are different risk factors for the pro-gression of primary biliary cirrhosis[J].Hepatology, 2007, 45 (1) :118-127.
|
|
[19]Poupon R, Chazouilleres O, Balkau B, et al.Clinical and bio-chemical expression of the histopathological lesions of prima-ry biliary cirrhosis[J].J Hepatol, 1999, 30 (3) :408-412.
|
|
[20]Degott C, Zafrani ES, Callard P, et al.Histopathological studyof primary biliary cirrhosis and the effect of ursodeoxycholic acidtreatment on histology progression[J].Hepatology, 1999, 29 (4) :1007-1012.
|
|
[21]Wesierska-Gadek J, Penner E, Battezzati PM, et al.Corre-lation of initial autoantibody profile and clinical outcome in pri-mary biliary cirrhosis[J].Hepatology, 2006, 43 (5) :1135-1144.
|
|
[22]Nakamura M, Takii Y, Ito M, et al.Increased expression ofnuclear envelope gp210 antigen in small bile ducts in primarybiliary cirrhosis[J].J Autoimmun, 2006, 26 (2) :138-145.
|
|
[23]Clouston AD, Powell EE, Walsh MJ, et al.Fibrosis corre-lates with aductular reaction in hepatitis C:roles of impairedreplication, progenitor cells and steatosis[J].Hepatology, 2005, 41 (4) :809-818.
|
|
[24]Lazaridis KN, Strazzabosco M, Larusso NF.The cholangiop-athies:isorders of biliary epithelia[J].Gastroenterology, 2004, 127 (5) :1565-1577.
|
|
[25]Gressner AM, Weiskirchen R.Modern pathogenetic conceptsof liver fibrosis suggest stellate cells and TGF-beta as majorplayers and therapeutic targets[J].J Cell Mol Med, 2006, 10 (1) :76-99.
|
|
[26]宫颜英, 王斯文, 房淑华, 等.晚期原发性胆汁性肝硬化患者外周血调节性T细胞表达分析[J].细胞与分子免疫杂志, 2011, 27 (3) :307-309.
|
DownLoad: